Last reviewed · How we verify
NCT03553706: DownSy
Indicators of Growth, Nutritional Status and Comorbide Disorders of Newborns With Down Syndrome
trial in Down Syndrome,Auxological Indexes, Auxological Parametars, Intrauterine Growth Restriction in 141 participants. Completed in 30 May 2018.
30 May 2018
Quick facts
| Lead sponsor | University Hospital of Split |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 141 |
| Start date | 20 May 2018 |
| Primary completion | 30 May 2018 |
| Estimated completion | 30 May 2018 |
| Sites | 1 location across Croatia |
Conditions studied
- Down Syndrome,Auxological Indexes, Auxological Parametars, Intrauterine Growth Restriction — all drugs for Down Syndrome,Auxological Indexes, Auxological Parametars, Intrauterine Growth Restriction →
Sponsor
University Hospital of Split
Who can join
Adults 1 Day to 1 Month, any sex, with Down Syndrome,Auxological Indexes, Auxological Parametars, Intrauterine Growth Restriction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective To access predictive values of the auxological parameters and indexes for risk of comorbid malformations in newborns with Down syndrome (DS) Study design In this cohort retrospective study, 141 newborns with proven trisomy 21 born at the Department of Gynecology and Obstetrics of the University of Split Hospital (1990 to 2015) were included. The data were obtained from the medical histories of mothers, infants and the delivery protocol. The objective was to access predictive values of the auxological parameters and indexes for risk of comorbid malformations in newborns with Down syndrome (DS) Conclusion Higher CI were found in hyportrophic (SGA) newborns with DS and indicated their intrauterine growth restriction with brain sparing and increased further risk of severe psychomotor retardation. The SGA newborns have lower parameters and indexes of nutritive status and significantly differed from eutrophic and hypertrophic newborns. These SGA newborns with DS have increased developmental risks and that requires further diagnostic attention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of Neonatal Body (Dis)Proportionality Determined by the Cephalization Index (CI) on Gross Motor Development in Children with Down Syndrome: A Prospective Cohort Study.
Rota Čeprnja A, Pranić SM, Šunj M, Kozina T, et al · · 2022 · PMID 36670564 · DOI 10.3390/children10010013
Verify or expand the search:
- PubMed search for NCT03553706
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital of Split trials
Trials by the same sponsor.
- NCT07130006 — Preoperative Use of Peripheral Nerve Blocks in Elderly Patients With Hip Fractures · Phase 4 · not yet recruiting
- NCT06595329 — Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy · Phase 1 · recruiting
- NCT06399445 — Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizin · Phase 4 · recruiting
- NCT06051825 — Diagnostic Importance of the C-reactive Protein From Blood and Saliva in Children With Acute Appendicitis · unknown
- NCT05537272 — The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03553706 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital of Split
- Last refreshed: 12 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03553706.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing